Porton Pharma Solutions is a global CDMO that provides preclinical through commercial solutions for small molecule, large molecule, and cell and gene therapies. Headquartered in China, Porton has over 20 facilities across Asia, Europe, and North America. The company is a one-stop CDMO, providing customized development and manufacture of small molecule drug substances, peptides, and oligonucleotides spanning the entire drug life cycle.
